Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
 
Home
 
Registration
Keynote Speakers (TBA)
Industry Panel Discussion (TBA)
Download Brochure


The Largest East Coast Strategic Partnership and Investment Meeting for Medical Technology Executives

NEW! Don’t miss the latest updates-directly from the FDA!

Panel, June 24, 2009, 1:30-2:30 pm

Working Successfully With FDA – Priorities Under the New Administration

  • Understand the agency’s current thinking on 510(k) clearance
  • Learn about CDRH’s new program to reclassify many devices
  • Get FDA tips on ensuring data integrity in your clinical trials

Mary Houghton
Executive Editor
The Gray Sheet

Heather S. Rosecrans
Director, 510(k) Staff
FDA Center for Devices and Radiological Health

Michael Marcarelli
Director, Division of Bioresearch Monitoring, Office of Compliance
FDA Center for Devices and Radiological Health

Invest, Partner and Network with THE Most Senior-Level Investors and Regulators in the Business:

Heather S. Rosecrans
Director, 510(k) Staff
FDA Center for Devices and Radiological Health

Michael Marcarelli
Director, Division of Bioresearch Monitoring, Office of Compliance
FDA Center for Devices and Radiological Health

Steven Weinstein
Managing Director
Novartis Venture Funds

John B. Henneman, III
EVP, Finance & Administration and CFO
Integra LifeSciences Corporation

Dennis Crowley
Vice President, Corporate Development
Covidien

Ted Davis
Vice President, Business Development
Wright Medical Technology

Izi Vruker
Vice President, Research & Development
Depuy-Mitek/Johnson & Johnson

Paul LaViolette
Venture Partner
SV Life Sciences

Matt Rieke
Partner
Quaker Bioventures

Daniel Sheehan
Vice President
Covidien Ventures

Albert Lauritano, MSc, CLP
Director, Business Development
Becton Dickinson (BD)

Anupendra Sharma
Investment Partner
Siemens Venture Capital, Inc.

 

Investment-in-Innovation (In3) conferences are the premier forums worldwide for discerning senior executives in the medical device, diagnostics, biotech, and pharmaceutical business development and investment communities to meet and screen promising medical technology companies in need of funding, acquisition and/or strategic partnership, and to network with key decision makers in the industry. Click here to see a video describing why you should attend IN3 conferences: Launch Video

In3 East is simply where you will meet the most important people in medical technology partnering.
As the largest East Coast strategic partnership and investment meeting for senior-level medical technology executives, hundreds of venture capital companies and medical technology companies gather each year to hear about the latest innovations and investment opportunities, especially in the following areas:

  • Cardiovascular/Interventional Cardiology
  • Diagnostics
  • Drug Delivery
  • Imaging
  • Minimally Invasive Surgery
  • Nanotechnology
  • Neurostimulation
  • Orthopedics/Spine
  • Peripheral Vascular
  • Stem Cells
  • Stroke Management
  • Wound Management

... among many other high-growth areas

And when you’re not networking, you’ll benefit from any of the following discussed at the meeting:

  • Keynote presentations, on-stage interviews, investment and financing panel discussions by prominent device industry executives
  • Venture capital dealmaking presentations
  • Buy side panels
  • Educational workshops for start-up companies
  • Company presentations from more than 50 emerging medical technology companies seeking funding and/or strategic partnership

For more information, please contact Kristy Grimes at 480-985-9512, 888-202-5939 toll-free in the U.S., or e-mail in3@windhover.com
Advisory Board

Jeffrey Barnes
General Partner
Oxford Bioscience Partners

Annette Campbell-White
Senior Managing Member MedVenture Associates

Michael Carusi
General Partner
Advanced Technology Ventures

Luke Evnin
General Partner
MPM Capital

Richard M. Ferrari
Managing Director
DeNovo Ventures

William T. Harrington
Partner
Three Arch Partners

Ross A. Jaffe
Managing Director
Versant Ventures

Ellen Koskinas
Partner
InterWest Partners

Josh Makower
Venture Partner
NEA

John Maroney
General Partner
Delphi Ventures

Allan May
Chairman, Founder
Life Science Angels
Managing Director
Emergent Medical Partner

David Milne
Managing Partner
SV Life Science Advisers

Trevor J. Moody
Partner
Frazier Healthcare Ventures

Jesse I Treu
Partner
Domain Associates
back to top

Program Agenda

January 01, 2008
0:00 - 0:00 AM test event 1
 

Top reasons to attend In3 East:

  • Catch up on the state of medical technology investment and partnering
  • Network with peers who face similar challenges in regulatory, reimbursement and clinical issues for medical devices
  • Benchmark your dealmaking against the best and the brightest
  • Winners and losers: Find out which companies and technologies are worth the investment
  • Get key trend analysis on medical technology deal structures
  • Maximize your strategic alliance opportunities by meeting business development leaders who’ll share practical advice and strategies on how to structure successful deals
  • Walk away with practical, real-life lessons from some of the most experienced dealmakers in the industry in the medical technology marketplace
  • Attended by senior-level decision-makers from the investment community and major medical technology, biopharmaceutical, biotech, venture capital and other companies
  • More than 50 participating companies
  • 10-minute presentations immediately followed by private, one-on-one meetings with company representatives
  • A range of technologies for such high-growth segments of the medtech industry as interventional cardiology, spinal and orthopedic surgery, drug delivery technology, and stroke management

Maximize your strategic alliance opportunities by hearing C-level, venture capital and business development executives who share lessons learned, practical advice and strategies on medical technology dealmaking.

In3 East has the most senior execs in attendance:

  • Presidents
  • CEOs
  • Chairmen
  • Venture Partners
  • Managing Directors
  • Vice Presidents/Directors of Business Development, Marketing, New Technology, Acquisitions, R & D & Sales
  • Senior Investment Analysts/Managers/Directors

If you're on this list, you must attend this meeting.

  • Established medical technology companies seeking technology through licensing, partnering and acquisition to broaden or deepen product lines or build sector strength
  • Venture capitalists and investment bankers
  • Medical device, biotech, biopharmaceutical or other company executives seeking investments or partnerships
back to top

Presenting Companies

Presenting Companies
Locations		 Technologies
Test Company
Test Location 		Test Technology

 

*Cancellation Policy: Refunds will only be given through May 23, 2009. Paid cancellations thru May 23, 2009 will incur a $300 processing fee. Cancellations after May 23, 2009 will only be allowed a replacement attendee. No other credit, transfer, or refund will be offered.
 


Sponsored by:

Life Science Intelligence

Major Supporting Publications

Medtech Insight


Marketwire
Official Wire Service for In3 Conferences